IRVINE, CA -- Cyvex Nutrition, Inc., a leading US developer and distributor of branded nutraceutical ingredients, has announced a settlement of litigation initiated by Laboratoires Expanscience S.A, a pharmaceutical company based in Courbevoie, France.
Cyvex Nutrition, according to founder and CEO Gilbert Gluck, admitted no wrongdoing to the claims made against it by Laboratoires Expanscience. “In an effort to move forward and put this matter behind us, we have re-evaluated our marketing and promotional approach for our avocado-soy unsaponifiables”.
Under terms of the settlement, Cyvex Nutrition will no longer refer to its avocado soy unsaponifiables nutraceutical ingredients using trademarks and abbreviated terms it used in previous promotions and advertising materials. Gluck assures that Cyvex’ avocado soy unsaponifiables are guaranteed to contain 30 percent avocado and soy phytosterols (two parts soy/one part avocado).
Cyvex Nutrition, Inc. has been actively engaged in the research, development and marketing of natural compounds for two decades and has earned an impeccable reputation. Its portfolio of branded, trademarked ingredients includes ArthroColl® chicken collagen type II, BioCosanol™ rice policosanol, BioVinca® vinpocetine and Lactocalcium™ brand of milk minerals among others. Cyvex Nutrition, Inc. also developed the NutriPrint™ system, a stringent quality program applied to all its products.